HMMR anticorps (C-Term)
Aperçu rapide pour HMMR anticorps (C-Term) (ABIN951207)
Antigène
Voir toutes HMMR AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 675-705, C-Term
-
Specificité
- This antibody recognizes Human CD168 / HMMR (C-term).
-
Purification
- Protein A column, followed by peptide affinity purification
-
Immunogène
- KLH conjugated synthetic peptide between 675-705 amino acids from the C-terminal region of human CD168 / HMMR
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- HMMR (Hyaluronan-Mediated Motility Receptor (RHAMM) (HMMR))
-
Autre désignation
- CD168 / HMMR
-
Sujet
- The protein encoded by this gene is involved in cell motility. It is expressed in breast tissue and together with other proteins, it forms a complex with BRCA1 and BRCA2, thus is potentially associated with higher risk of breast cancer. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene.Synonyms: Hyaluronan mediated motility receptor, IHABP, Intracellular hyaluronic acid-binding protein, RHAMM, Receptor for hyaluronan-mediated motility
-
Poids moléculaire
- 84100 Da
-
ID gène
- 3161
-
NCBI Accession
- NP_001136028
-
Pathways
- Glycosaminoglycan Metabolic Process
Antigène
-